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ShockBackground: Cardiovascular reserve index (CVRI) was previously proposed as an estimate of the assumed
(momentary) cardiovascular reserve as a function of stroke volume (SV), systemic vascular resistance (SVR),
respiratory rate (RR) and body surface area (BSA). Conversion through conventional hemodynamic equations re-
veals an equivalent, simpler, vital signs based function. We evaluated the association between CVRI and diverse
conditions along the hemodynamic spectrum.
Methods: CVRI was retrospectively computed for each subject of 3 existing patient databases. 1) Acute severe
hospital admissions [N = 333] classiﬁed by disease course to: “shock on arrival”, “developing shock” and
“non-shock”. 2) Heart failure (HF) patients [N = 71] classiﬁed by HF severity to: mild, moderate and severe
HF. 3) Cardio-pulmonary exercise testing (CPX) [n= 387] classiﬁed by exercise capacity (EC) to: normal, mildly
decrease, moderately decrease and severely decreased EC. CVRI association with these hemodynamic conditions
was evaluated through ANOVA.
Results: ‘Normal EC’ has the highest CVRI of 0.97 (0.88, 1.06), and in decreasing CVRI order ‘mildly decrease EC’,
‘moderately decrease EC’, ‘mild HF’whichwas similar to ‘severely decrease EC’, ‘moderate HF’whichwas similar
to acute severe admission of ‘non-shock’, ‘severe heart failure’ which was similar to ‘developing shock’ and the
lowest CVRI was observed in ‘shock on arrival’ with mean CVRI of 0.20 (0.19, 0.22), ANOVA p b 0.001.
Conclusions:MeanCVRI exhibited consistent inverse associationwith the severity of the hemodynamic condition.
However, CVRI clinical utility of an individual patient requires further studies.
© 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
The cardiovascular reserve hypothesis was proposed by Gabbay and
Bobrovsky [1] as the common denominator for aerobic exhaustion, the
diverse types of heart failure and the diverse shock types.
Exercise capacity (EC) can be deﬁned as the highest work intensity
that an individual can achieve. Even in ﬁt, healthy individuals EC is not
unlimited hence when exercise intensity reaches the highest worktive Medicine Department, The
l-Aviv University, Ramat Aviv,
en access article under the CC BY-NCintensity possible the individual must either stop work or reduce the
intensity. Reduced EC may be still considered within the scope of nor-
mal health, for example in sedentary, deconditioned individuals. Var-
ious disease states reduce EC, inducing physical activity intolerance
which limits daily living (i.e. heart failure) [2]. Heart failure (HF) is a
diverse syndrome with several underlying causes, that commonly
manifests as fatigue and dyspnea either at rest or while performing in-
signiﬁcant physical activity considerably below that expected in the
healthy. The mechanism of the limitation is either low or high cardiac
output [3].
Shock refers to generalized inadequate perfusion which triggers a
chain of devastating consequences (cellular hypoxia, anaerobic metab-
olism, cell death, organ failure) inevitably leading to death in the ab-
sence of effective intervention. The underlying mechanism is either
low cardiac output, or low systemic vascular resistance, or both [4,5].-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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scribed as themomentary hemodynamic capability to adapt to increasing
metabolic demand. Accordingly, a healthy, ﬁt subject at rest has maximal
reserve. A healthy but unﬁt subject has reduced exercise capacity that
only limits high intensity activity. Heart failure patients are expected to
have even lower cardiovascular reserve, inversely related to the severity
of the HF, which limits them even in daily activities. The cardiovascular
reserve is expected to decrease during exercise (in accordance with
the activity intensity) until it reaches an assumed (common) exhaus-
tion threshold, at which point dyspnea and exhaustion prevent gaining
or even restoring this activity. The healthy, well trained individual may
reach the exhaustion threshold with extremely intensive exercise (due
his high cardiovascular reserve at rest). HF patients are expected to
reach the exhaustion threshold with low-intensity activity (due to
low cardiovascular reserve at rest). An acute illness which is associated
with hemodynamic deterioration (e.g. myocardial infarction, hypovole-
mia or sepsis) may decrease the assumed cardiovascular reserve, ac-
cording to the hypothesis, below the exhaustion threshold even with
no activity. In these severely ill patients the assumed cardiovascular re-
servemay further deteriorate toward an assumed sustainability limit in
which shock is manifested [1].
In order to quantify the assumed cardiovascular reserve, a cardio-
vascular reserve index (CVRI) was proposed, based on a theoretical
analysis of the cardiovascular open loop gain (OLG) [6]. OLG is a control
engineering term which indicates the robustness of a control system to
response for increasing demand [7]. OLG is proportional to the product
of the gains of each individual element in a control loop. As already
known the cardiovascular feedback mechanism is mainly composed of
three elements: the heart, for which the main gain is stroke volume
(SV); the vasculature and blood volume, for which themain gain is sys-
temic vascular resistance (SVR); and baro-receptor sensitivity. Several
studies indicate that the baro-receptor sensitivity is reciprocally associ-
atedwith respiratory rate (RR) [8]. CVRIwas thus proposed as the prod-
uct of SV, SVR and 1/RR, divided by Body Surface Area (BSA) (to
normalize for size), and by 4 (in order to normalize CVRI of a healthy in-
dividual to approximately 1.0) [9]:
CVRI ¼ SVSVR= RRBSA4ð Þ ð1Þ
As neither SV nor SVR can be reliably measured non-invasively, and
given that SV = CO / HR (where CO is cardiac output and HR is heart
rate) and SVR=80 ∗ (MABP− CVP) / CO (whereMABP ismean arterial
blood pressure, CVP is central vein pressure and CO is cardiac output),
conversion of SV and SVR accordingly provides an equivalent CVRI for-
mula which is considerably simpler to measure [9]:
CVRI ¼ 20 MABP−CVPð Þ= RRHRBSAð Þ: ð2Þ
The aim of this study was to perform a proof-of-principle pilot
empirical validation whether or not CVRI correlates with the assumed
cardiovascular reserve over awide range of conditions across the hemo-
dynamic spectrum.
2. Methods
The study was designed as correlative study between CVRI (retro-
spectively computed out of the documented physiological measures of
existing patients' data) and diverse hemodynamic conditions. In order
to cover the entire hemodynamic spectrum, we utilized three unrelated
databases in which each patient record included a predetermined he-
modynamic condition (as already determined in the data base) and
the essential physiological measurements through which CVRI may be
retrospectively computed i.e. blood pressure, CVP, HR and RR. Missing
measurements of CVP and BSA were tolerated as described below. The
three databases included in the study were:1) A compilation of case reports of acute severe hospital admissions
(either illness or injury) published in peer reviewed journals during
2000–2012. The search terms used to search case reports in Pub-
Med were: ‘acute admission’, ‘case report’, ‘severe’ and ‘respiratory’.
The inclusion criteria were case reports of acute severe hospital ad-
missions, in which the condition at admission and the acutemorbid-
ity course were reported by the authors (enabling classiﬁcation to
one of the three study sub-groups according to the course of the
acute illness: “shock on arrival”; “developing shock” in those
where shock was not yet onset on admission, but developed later
on in the course of the acute illness; and “Non-shock” — admissions
of acute severe illness inwhich shockwas not developed at all. Inclu-
sion criteria included reporting of the physiological measurements
at admission, from which CVRI was computed independently of
the above mentioned classiﬁcations.
2) A compilation of case reports of case reports of HFpatients published
in peer reviewed journals during 2000–2012. The search terms used
to search case reports in Pub-Med were: ‘heart failure’, ‘case report’,
‘severity’ and ‘respiratory’. The inclusion criteria were HF case re-
ports which reportedHF Classiﬁcation asmild, moderate, and severe
HF. Inclusion criteria included the reporting of the physiological
measurements from which CVRI was computed independently of
the HF classiﬁcations.
3) The database of patients who underwent cardio-pulmonary exercise
testing (CPX) due to diverse clinical indications at the Lung institute;
Sheba Medical Center, Ramat-Gan, Israel, which were already cate-
gorized by the CPX to four sub-groups of exercise capacity (EC): nor-
mal EC, mildly decreased EC, moderately decreased EC and severely
decreased EC. The inclusion criteria included the physiological mea-
surements at rest (before exercising) fromwhich CVRI was comput-
ed independently of the EC classiﬁcations. The protocol was
approved by the Sheba Medical Center ethics committee. The re-
quirement for informed consent was waived as the study involved
a retrospective analysis of de-identiﬁed data.2.1. Data structure
Individual patients' data were entered into a single record which in-
cluded demographic data,morbidity type, data source, sub-group classi-
ﬁcation and the vital signs measurement at the initial evaluation for
retrospective CVRI computing.2.2. Data processing and statistical analysis
CVRI was calculated for each record according to the vital signs
based formula for CVRI (Eq. (2), above). For the purpose of this work
CVRI may be considered as unit-less index.
If blood pressure measurement was reported as systolic/diastolic,
MABP was calculated using the formula [10]:
MABP ¼ DBPþ SBP−DBPð Þ=3
where DBP is diastolic blood pressure and SBP is systolic blood pressure.
If the record lacked measurements of either CVP or BSA, the follow-
ing estimation methods were used:
Missing CVP measurement—when CVP was clinically described as
elevated or considerably elevated (e.g. clinical description of cervical
vein distension) we imputed CVP as 10 mmHg, and 15 mm Hg respec-
tively. When CVP was described as decreased we imputed CVP as
3 mm Hg.
When CVPwas neither reported nor clinically described, we assume
that CVP may be approximated as 10% of MABP.
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the Mosteller formula [11]:
BSA ¼ HW=3600ð Þ0:5
where ‘H’ is height in cm and W is weight in kg.
In cases where neither height nor weight was reported, adult BSA
was estimated by gender according to Sacco et al. [12]:
BSA ¼ 1:91 m2 for male patients:
BSA ¼ 1:71 m2 for female patients:
In caseswhere height andweightwere not reported but BMIwas re-
ported, then the abovementioned estimated BSAwas corrected bymul-
tiplying the estimated BSA by a correcting factor = (BMI / 25)0.5.
In cases in which only body composition was reported it was con-
verted into the respective BMI representative value: “obesity”was con-
verted to BMI=30, “morbid obesity”was converted to BMI=40,” thin”
was converted as BMI= 20 and “cachectic”was converted to BMI= 17
[13]. Accordingly, the estimated BSAwas corrected asmentioned above.
Sub-group speciﬁc CVRI averages and the respective 95% conﬁdence
intervals were calculated for each study sub-group (ten in total) of all
three databases. Sub-group multi-comparisons statistics were per-
formed using one-way ANOVA.
3. Results
3407 case reports of acute severe hospital admissions were found,
333 of which (9.8%) complied with the inclusion criteria described
above. Themost limiting criterionwas respiratory ratewhichwas infre-
quently reported.
1921 case reports of heart failure patients were found, only 71 of
which (3.7%) complied with the inclusion criteria. The most limiting in-
clusion criterion was respiratory rate which was rarely reported.
400 consecutive patients of the Sheba CPX databasewho underwent
CPX were retrieved, 387 of which (96.5%) complied with the inclusion
criteria described above.
Table 1 presents the patients characteristics by database and group.
The ‘Acute severe hospital admissions’ database patients were relatively
young (average age of 45.0 years) with slight male predominance (56%
males). The ‘heart failure’ database patients were similar to the ‘acute
severe hospital admissions’ in gender composition (55% males), but
were signiﬁcantly older, (average age of 49.6 years, p = 0.05). The
CPX database patients were not different in gender composition with
52% males, but the patients were signiﬁcantly older than those in the
other two databases, with an average age of 54.6 years (p b 0.05).Table 1
Patient characteristics by database and by sub-group.
Database Sub-group Number Gender
(% males)
Age (95% CI)
Acute severe
hospital
admissions
All 333 56.2% 45.0 (42.7, 47.3)
Shock on arrival 98 53.1% 46.7 (42.8, 50.7)
Developing Shock 65 55.4% 42.1 (36.8, 47.4)
Non-shock 170 57.6% 45.0 (41.6, 48.4)
Heart failure All 71 56.0% 49.6 (44.6, 54.7)
Mild HF 15 60.0% 43.3 (28.8, 57.8)
Moderate HF 16 37.5% 53.4 (41.4, 65.5)
Severe HF 40 60.0% 50.5 (45.3, 55.7)
Cardio-pulmonary
exercise testing
(CPX)
All 387 52% 54,6 (52.9, 56.3)
Normal EC 67 35% 59.0 (54.4, 63.5)
Mildly decreased EC 105 46% 55.3 (51.7, 58.9)
Moderately decreased
EC
96 54% 54.8 (51.4, 58.1)
Severely decreased EC 119 67% 52.2 (49.2, 55.1)Fig. 1 shows CVRI statistics (mean and 95% CI) for all sub-groups (ten
in total) across all three databases, in decreasing order. Within each da-
tabase, mean CVRI values of the sub-groups reﬂect the expected ordinal
order. For example, in the CPX database, thosewith normal exercise ca-
pacity have the highest CVRI 0.97 (95% CI: 0.88, 1.06), followed by the
mildly decreased EC sub-group 0.87 (0.80, 0.94), the moderately de-
creased EC sub-group 0.81 (0.76, 0.86) and ﬁnally the severely de-
creased EC sub-group 0.68 (0.64, 0.72) (ANOVA p b 0.001).
In the HF database the CVRI of the mild HF group 0.71 (95% CI: 0.65,
0.78) was higher than that of the moderate HF sub-group 0.58 (0.48,
0.68), which was higher than that of the severe HF sub-group 0.39
(0.35, 0.42); (ANOVA p b 0.001).
Finally, in the acute severe hospital admissions database the ‘shock
on arrival’ sub-group had the lowest mean CVRI 0.20 (95% CI: 0.19,
0.22), followed by the developing shock sub-group had intermediate
mean 0.40, (0.35, 0.45) and the highest in the ‘non shock’ sub-group
with CVRI 0.57 (0.52, 0.62); (ANOVA p b 0.001). Notably, within the
‘shock in admission’ sub-group there were similar CVRI with no signiﬁ-
cant differences by different types of shock. Twenty-one of 98 (21.4%)
had hypovolemic/hemorrhagic shock with CVRI of 0.24 (0.20, 0.28),
51 (52.0%) had distributive shock with CVRI of 0.20 (0.19, 0.21) and
26 (26.5%) had cardiogenic/obstructive shock with CVRI of 0.19 (0.18,
0.20) (ANOVA p = 0.13).
Moreover, when the entire spectrum of 10 sub-groups of the 3 data-
bases is considered, the mean CVRI values also seem to conform the in-
tuitive expectation. Thus we see, in descending order, the normal EC
sub-groups followed by the mildly and moderately reduced EC sub-
groups. Further down the “CVRI totem pole” we see similar mean
CVRI values in the mild HF and severely reduced EC sub-groups. Next
we see the moderate HF sub-group and non-shock (of the acute severe
hospital admissions database) which have similar mean CVRIs. These
are followed by a signiﬁcant drop of CVRIs observed in the developing
shock sub-group and severe HF sub-groups, which have similar mean
CVRIs, and the lowest CVRI values are seen in shock on admission sub-
group, regardless of the shock type.
4. Discussion
The present study presents an initial preliminary evaluation of CVRI
potential as an estimate of the assumed momentary cardiovascular re-
serve. The results reveal an intuitive association between CVRI and di-
verse conditions along the entire hemodynamic spectrum: The highest
CVRI (mean 0.97) was measured in the healthy normal EC sub-group.
Mean CVRI decreased with the hemodynamic severity of the sub-
groups. The lowest CVRI mean was measured in shock on arrival
(mean 0.20) regardless of shock type.
The similarity in mean CVRI in apparently different sub-groups of
unrelated databases may be assumed as similar hemodynamic compro-
mises. For example: the similarity in CVRI of the ‘severely decreased EC’
sub-group to the ‘mild HF’ sub-group. As noted earlier, decreased EC
may still be within the scope of healthy untrained patients. However,
severe decrease in EC may be considered limiting daily activities and
hence morbid (i.e. overlap the deﬁnition of heart failure). Thus, the ‘se-
verely decreased EC’ sub-group may overlap the ‘mild HF’ sub-group.
It also seems logical that the ‘moderate HF’ sub-group have a similar
degree of hemodynamic compromise as the ‘non-shock’ sub-group (of
the ‘acute severe hospital admissions’ database). Previous publications
have already pointed toward the similarity in manifestation of heart
failure in acute morbidities and conditions such as hypovolemia and
sepsis [3].
Similarly it is reasonable to consider that the ‘severe HF’ sub-group
may carry similar hemodynamic characteristics as ‘developing shock’
sub-group. The Task Force on Acute Heart Failure of the European Soci-
ety of cardiology has declared that there is “a continuum” spectrum
from heart failure to cardiogenic shock” [3]. Hence the similarity be-
tween severe HF and developing shockmay eventually be inconclusive.
Fig. 1.CVRI statistics (mean and 95% conﬁdence interval) of patient sub-groups, arranged (left to right) in decreasing order ofmeanCVRI. Footnotes: – Triangles (Δ) denote themeanCVRIs
of the sub-groups of the CPX database. – Circles (○)— sub-groups of theHF database. – Squares (□)— the sub-groups of the acute severe admission database. – Sub-group designations are
noted below the horizontal axis. – EC— exercise capacity. – HF — heart failure. – CPX — cardiopulmonary exercise testing.
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SVR is low). Shock is attributable to either low cardiac output or low
SVR or both [14]. The results associate shock with low CVRI i.e. either
a decrease in SV or SVR or both which complies with the above as SV
is proportional to CO (SV = CO/HR).
This work has several limitations. Studies utilizing retrospective
data are prone to biases. However, retrospective data is an accept-
able and appropriate method for the initial evaluation of a potential
predictor. Another considerable limitation is the use of entirely unre-
lated data sources. Moreover, the databases of ‘acute severe hospital
admissions’ and ‘heart failure’ were composed of case reports in
which patient diagnosis cannot be considered standardized, and by
turn may had caused inconclusiveness and inconsistency. Unfortu-
nately, we did not ﬁnd a single database that covers the entire hemo-
dynamic spectrum which enables retrospective computation of
CVRI. The estimations and approximations of some of the variables
were an inevitable compromise in order to compute CVRI. MABP es-
timated from SBP and DBP does not take into account the actual
blood pressure waveform though it is a routine practice. The approx-
imation of BSA may be deviated from the actual value. The approxi-
mation of CVP as 10% of MABP or according to clinical ﬁndings may
have introduced bias especially in cases where the underlying im-
pairment was either cardiogenic or obstructive.
5. Conclusions
Our results provide an initial preliminary empirical validation of
CVRI as a potential estimate of the assumed momentary cardiovascular
reserve and accordingly its association with the hemodynamic condi-
tion along the hemodynamic spectrum.
CVRI can be easily measured, through simple vital sign measure-
ments, whichmay be independent of medical device or medical facility.
CVRI characteristics, namely being a continuous variable, its mono-
tonicity along the hemodynamic spectrum and its ease of measurement
may enable detection of deterioration toward shock before shock is
manifested or even considered in the case of the acute morbidity and
enable measurable index for follow-up of the chronic HF.These preliminary results should be validated in further studies.
The question whether CVRI has diagnostic or prognostic importance
for the individual patient is still to be investigated through prospec-
tive studies.
Abbreviations
BMI body mass index
BSA body surface area
95% CI 95% conﬁdence interval
CVP central vein pressure
CVRI cardio-vascular reserve index
DBP diastolic blood pressure
HR heart rate
MABP mean arterial blood pressure
RR respiratory rate
SBP systolic blood pressure
SV stroke volume
SVR systemic vascular resistance
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